GL1X · GenesisL1 explorer

MolNFT v1 · #188179 · protein

Cryo-EM structure of SARS-cov-2 kappa (B.1.617.1) spike protein (focused refinement of rbd)

7TF4 · Spike glycoprotein: “Cryo-EM structure of SARS-cov-2 kappa (B.1.617.1) spike protein (focused refinement of rbd)”. Electron microscopy, 1 ligand (NAG), 20 pockets (best druggability 0.75). MolNFT v1 #188179 on GenesisL1: 3D…

PDB
7TF4
Type
protein
Length
1,608 residues
Chains
6
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein
UniProt
P0DTC2
Ligands
NAG
Pockets
20 · best druggability 0.75

Structure

electron microscopy · 1 distinct chain · 10% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, FSpike glycoproteinprotein26810% helix, 33% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 12 copies · chains A, B, C, D, E, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11150.750.9524empty
2830.730.9620empty
3950.720.9423empty
45210.690.7934empty
54280.620.7631empty

Interfaces

6 interfaces between chains.

  • B–F · 753 Ų buried · 11 hydrogen bonds · protein-protein
  • A–D · 728 Ų buried · 11 hydrogen bonds · protein-protein
  • C–E · 695 Ų buried · 10 hydrogen bonds · protein-protein
  • C–F · 571 Ų buried · 9 hydrogen bonds · protein-protein
  • A–E · 558 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 24 disulfide, 12 glycan (disulfide, N-glycosylation).

Compared structures

  • 7TF4 · Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.